Adrenal activity and metabolic risk during randomized escitalopram or placebo treatment in PCOS
Background/aims: Polycystic ovary syndrome (PCOS) is associated with insulin resistance, adrenal hyperactivity and decreased mental health. We aimed to investigate the changes in adrenal activity, metabolic status and mental health in PCOS during treatment with escitalopram or placebo. Methods: For...
Main Authors: | Dorte Glintborg, Magda Lambaa Altinok, Pernille Ravn, Kurt Bjerregaard Stage, Kurt Højlund, Marianne Andersen |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2018-03-01
|
Series: | Endocrine Connections |
Subjects: | |
Online Access: | http://www.endocrineconnections.com/content/7/3/490.full |
Similar Items
-
Bilateral Acute Angle-Closure Glaucoma Induced By Escitalopram
by: Dilbade Yıldız Ekinci, et al.
Published: (2014-10-01) -
Dosage-related nature of escitalopram treatment-emergent mania/hypomania: a case series
by: Yamaguchi Y, et al.
Published: (2018-08-01) -
Depression in acromegaly treated with escitalopram and cognitive therapy
by: De Sousa Avinash
Published: (2009-01-01) -
A Single Dose of Oral Escitalopram Decreases Resting-state Functional Connectivity
by: Burmann, Inga
Published: (2015) -
Comparison of the Effect of Escitalopram and Placebo on Quality of Life and Depressive Symptoms in Patients with Breast Cancer and Mastectomy
by: Fatemeh Rajabi, et al.
Published: (2018-11-01)